Medtronic CE marks graft delivery system
This article was originally published in Clinica
Executive Summary
Medtronic (Minneapolis, Minnesota) has CE marked its Captivia delivery system for sale in Europe. The device delivers the Valiant thoracic stent graft, a minimally-invasive treatment for aneurysms and other lesions of the thoracic aorta. The Captivia system, used to perform endovascular aortic repair (EVAR), has also been launched onto the international market. However, both it and the Valiant graft are investigational in the US, where their use is limited to clinical trials.